Biogen Inc.
Location
Massachusetts
Founded
1978-02-28
Website
Risk Signals
6605 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations, Biological Products, Except Diagnostic Substances, Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Biogen Inc.
Live alerts from global media, monitored by Business Radar
2025-02-08 (endpts.com)
Q4 earnings updates; Biogen details revised research strategy; RFK Jr. advances out of Senate committee; and more
Q4 earnings updates: BMS plans $2B in cuts, AZ makes pipeline changes, Merck pauses Gardasil in China, Pfizer eyes M&A. RFK Jr. advances for HHS role, Biogen talks R&D strategy.
Read more
2024-09-24 (webindia123.com)
Biogen CEO supports PM Modi''s views on inclusive technology for better healthcare
Biogen CEO Chris Viehbacher has praised PM Modi''s vision of making India central to the technological progress of the 21st century.
Read more
2024-09-24 (malaysiasun.com)
Holtec CEO lauds PM Modi's vision to support India's clean energy goals
Prime Minister Narendra Modi roundtable meeting with CEOs of global technology and energy companies in New York has sparked significant discussions on India
Read more
2023-01-07 (tovima.gr)
Read in "Sunday's Step" | News - news - Vima Online
The formula for the return of the Parthenon Sculptures
Read more
2023-01-04 (businessinsider.com)
Biotech investor Brad Loncar shares 10 predictions for 2023, including a hot new cancer target, Nobel Prize winners, and a biotech founder running for president
In his annual list of predictions, biotech investor Brad Loncar said the biotech industry likely has a mixed forecast for 2023.
Read more
2022-12-30 (usatoday.com)
Controversial Alzheimer's drug, explained: What to know about Aduhelm, FDA and scathing report
An investigation found the approval process for the controversial drug included \
Read more
2021-06-29 (statnews.com)
Inside ‘Project Onyx’: How Biogen used an FDA back channel to win approval of its polarizing Alzheimer’s drug
When Aduhelm’s prospects appeared dead, Biogen mounted a secret campaign to resurrect the drug and convince the FDA to approve it.
Read more
2020-06-07 (citybizlist.com)
Bristol-Myers Squibb: Growth And Valuation Trump Other Concerns
By Chuck Walston SA Summary While the Celgene acquisition added blockbusters to the company’s product portfolio, it comes with big debt and integration risk. Bristol’s top three drugs provide 69% of revenues. The patent cliffs are roughly a half
Read more
2016-10-12 (nature.com)
Biosimilars in IBD: from theory to practice
Biologic agents have revolutionized the management of IBD and biosimilars (copy versions of the originator agents) are emerging as an alternative. This Review outlines the concept of biosimilars and their adoption in gastroenterology, their current use and future challenges. Biologic agents have
Read more
(devdiscourse.com)
Health News Roundup: US FDA approves Biogen's ALS drug; North Dakota governor signs strict abortion bill into law and more | Health
But rape and incest victims would have to carry their pregnancies to term unless "the probable gestational age of the unborn child is six weeks or less," Senate Bill 2150 says. Biogen trims pipeline programs to cut costs, focus on Alzheimer 's drug launch Biogen Inc said on Tuesday it will pause or
Read more